Skip to main content
. 2023 Jul 7;110(10):1381–1386. doi: 10.1093/bjs/znad211

Table 3.

Rates of stenosis per clinical response evaluation until 16 months after nCRT in patients without tumour recurrence during active surveillance

3 months 6 months 9 months 12 months 16 months
Stenosis, easily traversable 15 (11.5) 6 (5.4) 8 (7.8) 7 (7) 7 (7)
 dysphagia score, median (i.q.r.); mean(s.d.) 0 (0–11.1); 6.8(9.7) 5.6 (2.8–8.3); 5.6(7.9) 0 (0–2.8); 2.8(5.6) 5.6 (0–11.1); 5.6(6.4) 0 (0–0); 0(0)
Stenosis, traversable with pressure* 1† (1) 3†‡ (3) 0 (0) 0 (0) 0 (0)
Non-traversable stenosis* 0 (0) 0 (0) 1† (1) 1† (1) 1† (1)
Total number of patients§ 131 111 102 98 97

Values are n (%) unless otherwise indicated. *No dysphagia scores were available for these patients as they did not participate in questionnaires. †Involves one patient with persistent dysphagia for solid food, but not for semi-solid food and liquids. Dilatation was not performed. ‡Involves one patient who underwent dilatation afterwards. Stenoses that were observed in further follow-up are censored from the table. §Defined as the number of patients with an available endoscopy report corresponding to the particular time point, without development of localized residual tumour within 4 months. i.q.r., interquartile range.